Treatment

According to official statistics from the WHO in 2022, oncological diseases are now the cause of one in every six deaths worldwide. This has encouraged the international medical community to develop new cancer treatment methods and increase the effectiveness of the already existing ones. This is particularly important for patients...

Parkinson's disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It occurs when dopaminergic neurons in the substantia nigra – a region of the brain responsible for coordinating motor control – begin to deteriorate. This leads to symptoms such as tremors, muscle rigidity...

Autoimmune diseases are a group of chronic disorders in which the immune system mistakenly attacks the body's own healthy cells and tissues. This immune misfiring leads to persistent inflammation, organ damage, and systemic complications. There are over 80 recognized autoimmune diseases, including rheumatoid arthritis, multiple...

Osteosarcoma tumors are a rare but aggressive form of bone cancer, most commonly affecting adolescents and young adults. In Germany, approximately 60 children and adolescents under 18 are diagnosed with osteosarcoma each year, accounting for about 2.6% of all pediatric malignancies in this age group. This cancer typically...

Soft tissue sarcomas are rare malignant tumors that develop in muscles, fat, cartilage, blood vessels, and other non-epithelial tissues throughout the body. With approximately 13,520 new cases expected in the United States in 2025, these cancers represent less than 1% of all cancer diagnoses. While advanced sarcomas differ...

Imagine a treatment that boosts your own immune response to fight lung cancer with precision, causing virtually no side effects while you maintain your daily routine. Dendritic cell therapy offers this possibility to patients at any cancer stage, showing effectiveness rates of 50-65% across various cancer types. With lung cancer affecting 226,650 new...

Dendritic cell prostate cancer treatment represents a groundbreaking immunotherapy approach, recognized by the 2011 Nobel Prize in Physiology or Medicine, awarded to Ralph Steinman. This innovative method can be prescribed to men of all ages and at any stage of prostate cancer, serving as an effective addition to standard treatment....

Standard therapy for glioblastoma includes surgical removal of the tumor in combination with chemotherapy or radiation therapy. With standard treatment of glioblastoma, the average life expectancy after diagnosis is 15-17 months, and the 5-year survival rate does not exceed 5-10%. Supplementing the standard protocol with the dendritic cell...